First human test of experimental drug AJ302-IM completed
NCT ID NCT06625541
Summary
This was a first-in-human study to check the safety and see how the body handles a new drug called AJ302-IM. It involved 57 healthy adult volunteers who received a single injection. The main goal was to find out if the drug was safe and to measure its levels in the blood and urine over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AnnJi Investigational Site
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.